Electric Therapy Traction Table Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
The global Prescription Weight Loss Pills market was valued at US$ 1162.7 million in 2022 and is projected to reach US$ 2259 million by 2029, at a CAGR of 10.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Oral Tablets Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Prescription Weight Loss Pills include Currax Pharmaceuticals (Contrave), VIVUS (Qsymia), Novo Nordisk A/S, Rhythm Pharmaceuticals (Imcivree), Eli Lilly and Company (TRICARE), CHEPLAPHARM (Xenical), Pfizer, Teva Pharmaceutical (Actavis) and Haleon Group (alli), etc. in 2022, the global top five players have a share approximately % in terms of revenue.
Health care professionals use the Body Mass Index (BMI), a measure of people weight in relation to height, to define overweight and obesity. People who have a BMI between 25 and 30 are considered to be overweight. Obesity is defined as having a BMI of 30 or greater. Are overweight, obese, or severely obese, which may increase risk of developing health problems. Obesity is a chronic disease and prescription medications to treat overweight and obesity work in different ways. Prescription weight loss medicines can help obese people lose weight. They are usually prescribed by a doctor when diet and exercise alone are not working. Each of these medicines works differently. People who use these medicines may not feel as hungry. Or they may feel full after eating only a small amount of food. Another type of weight-loss medicine makes it harder for your body to absorb fat. Prescription weight loss drugs can be helpful when used in combination with a low-calorie diet and regular physical activity.
This report aims to provide a comprehensive presentation of the global market for Prescription Weight Loss Pills, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prescription Weight Loss Pills. This report contains market size and forecasts of Prescription Weight Loss Pills in global, including the following market information:
Global Prescription Weight Loss Pills Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Prescription Weight Loss Pills Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Prescription Weight Loss Pills companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Prescription Weight Loss Pills manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prescription Weight Loss Pills Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Prescription Weight Loss Pills Market Segment Percentages, by Type, 2022 (%)
Oral Tablets
Oral Capsules
Injections
Global Prescription Weight Loss Pills Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Prescription Weight Loss Pills Market Segment Percentages, by Application, 2022 (%)
Hospital
Pharmacy
Global Prescription Weight Loss Pills Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Prescription Weight Loss Pills Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prescription Weight Loss Pills revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Prescription Weight Loss Pills revenues share in global market, 2022 (%)
Key companies Prescription Weight Loss Pills sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Prescription Weight Loss Pills sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Currax Pharmaceuticals (Contrave)
VIVUS (Qsymia)
Novo Nordisk A/S
Rhythm Pharmaceuticals (Imcivree)
Eli Lilly and Company (TRICARE)
CHEPLAPHARM (Xenical)
Pfizer
Teva Pharmaceutical (Actavis)
Haleon Group (alli)
Sanofi (Adlyxin)
AstraZeneca (BYDUREON BCise)
Outline of Major Chapters:
Chapter 1: Introduces the definition of Prescription Weight Loss Pills, market overview.
Chapter 2: Global Prescription Weight Loss Pills market size in revenue and volume.
Chapter 3: Detailed analysis of Prescription Weight Loss Pills manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Prescription Weight Loss Pills in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Prescription Weight Loss Pills capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Prescription Weight Loss Pills Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prescription Weight Loss Pills Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prescription Weight Loss Pills Overall Market Size
2.1 Global Prescription Weight Loss Pills Market Size: 2022 VS 2029
2.2 Global Prescription Weight Loss Pills Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Prescription Weight Loss Pills Sales: 2018-2029
3 Company Landscape
3.1 Top Prescription Weight Loss Pills Players in Global Market
3.2 Top Global Prescription Weight Loss Pills Companies Ranked by Revenue
3.3 Global Prescription Weight Loss Pills Revenue by Companies
3.4 Global Prescription Weight Loss Pills Sales by Companies
3.5 Global Prescription Weight Loss Pills Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Prescription Weight Loss Pills Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Prescription Weight Loss Pills Product Type
3.8 Tier 1, Tier 2 and Tier 3 Prescription Weight Loss Pills Players in Global Market
3.8.1 List of Global Tier 1 Prescription Weight Loss Pills Companies
3.8.2 List of Global Tier 2 and Tier 3 Prescription Weight Loss Pills Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Prescription Weight Loss Pills Market Size Markets, 2022 & 2029
4.1.2 Oral Tablets
4.1.3 Oral Capsules
4.1.4 Injections
4.2 By Type - Global Prescription Weight Loss Pills Revenue & Forecasts
4.2.1 By Type - Global Prescription Weight Loss Pills Revenue, 2018-2023
4.2.2 By Type - Global Prescription Weight Loss Pills Revenue, 2024-2029
4.2.3 By Type - Global Prescription Weight Loss Pills Revenue Market Share, 2018-2029
4.3 By Type - Global Prescription Weight Loss Pills Sales & Forecasts
4.3.1 By Type - Global Prescription Weight Loss Pills Sales, 2018-2023
4.3.2 By Type - Global Prescription Weight Loss Pills Sales, 2024-2029
4.3.3 By Type - Global Prescription Weight Loss Pills Sales Market Share, 2018-2029
4.4 By Type - Global Prescription Weight Loss Pills Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Prescription Weight Loss Pills Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Pharmacy
5.2 By Application - Global Prescription Weight Loss Pills Revenue & Forecasts
5.2.1 By Application - Global Prescription Weight Loss Pills Revenue, 2018-2023
5.2.2 By Application - Global Prescription Weight Loss Pills Revenue, 2024-2029
5.2.3 By Application - Global Prescription Weight Loss Pills Revenue Market Share, 2018-2029
5.3 By Application - Global Prescription Weight Loss Pills Sales & Forecasts
5.3.1 By Application - Global Prescription Weight Loss Pills Sales, 2018-2023
5.3.2 By Application - Global Prescription Weight Loss Pills Sales, 2024-2029
5.3.3 By Application - Global Prescription Weight Loss Pills Sales Market Share, 2018-2029
5.4 By Application - Global Prescription Weight Loss Pills Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Prescription Weight Loss Pills Market Size, 2022 & 2029
6.2 By Region - Global Prescription Weight Loss Pills Revenue & Forecasts
6.2.1 By Region - Global Prescription Weight Loss Pills Revenue, 2018-2023
6.2.2 By Region - Global Prescription Weight Loss Pills Revenue, 2024-2029
6.2.3 By Region - Global Prescription Weight Loss Pills Revenue Market Share, 2018-2029
6.3 By Region - Global Prescription Weight Loss Pills Sales & Forecasts
6.3.1 By Region - Global Prescription Weight Loss Pills Sales, 2018-2023
6.3.2 By Region - Global Prescription Weight Loss Pills Sales, 2024-2029
6.3.3 By Region - Global Prescription Weight Loss Pills Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Prescription Weight Loss Pills Revenue, 2018-2029
6.4.2 By Country - North America Prescription Weight Loss Pills Sales, 2018-2029
6.4.3 US Prescription Weight Loss Pills Market Size, 2018-2029
6.4.4 Canada Prescription Weight Loss Pills Market Size, 2018-2029
6.4.5 Mexico Prescription Weight Loss Pills Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Prescription Weight Loss Pills Revenue, 2018-2029
6.5.2 By Country - Europe Prescription Weight Loss Pills Sales, 2018-2029
6.5.3 Germany Prescription Weight Loss Pills Market Size, 2018-2029
6.5.4 France Prescription Weight Loss Pills Market Size, 2018-2029
6.5.5 U.K. Prescription Weight Loss Pills Market Size, 2018-2029
6.5.6 Italy Prescription Weight Loss Pills Market Size, 2018-2029
6.5.7 Russia Prescription Weight Loss Pills Market Size, 2018-2029
6.5.8 Nordic Countries Prescription Weight Loss Pills Market Size, 2018-2029
6.5.9 Benelux Prescription Weight Loss Pills Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Prescription Weight Loss Pills Revenue, 2018-2029
6.6.2 By Region - Asia Prescription Weight Loss Pills Sales, 2018-2029
6.6.3 China Prescription Weight Loss Pills Market Size, 2018-2029
6.6.4 Japan Prescription Weight Loss Pills Market Size, 2018-2029
6.6.5 South Korea Prescription Weight Loss Pills Market Size, 2018-2029
6.6.6 Southeast Asia Prescription Weight Loss Pills Market Size, 2018-2029
6.6.7 India Prescription Weight Loss Pills Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Prescription Weight Loss Pills Revenue, 2018-2029
6.7.2 By Country - South America Prescription Weight Loss Pills Sales, 2018-2029
6.7.3 Brazil Prescription Weight Loss Pills Market Size, 2018-2029
6.7.4 Argentina Prescription Weight Loss Pills Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Prescription Weight Loss Pills Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Prescription Weight Loss Pills Sales, 2018-2029
6.8.3 Turkey Prescription Weight Loss Pills Market Size, 2018-2029
6.8.4 Israel Prescription Weight Loss Pills Market Size, 2018-2029
6.8.5 Saudi Arabia Prescription Weight Loss Pills Market Size, 2018-2029
6.8.6 UAE Prescription Weight Loss Pills Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Currax Pharmaceuticals (Contrave)
7.1.1 Currax Pharmaceuticals (Contrave) Company Summary
7.1.2 Currax Pharmaceuticals (Contrave) Business Overview
7.1.3 Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Major Product Offerings
7.1.4 Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Sales and Revenue in Global (2018-2023)
7.1.5 Currax Pharmaceuticals (Contrave) Key News & Latest Developments
7.2 VIVUS (Qsymia)
7.2.1 VIVUS (Qsymia) Company Summary
7.2.2 VIVUS (Qsymia) Business Overview
7.2.3 VIVUS (Qsymia) Prescription Weight Loss Pills Major Product Offerings
7.2.4 VIVUS (Qsymia) Prescription Weight Loss Pills Sales and Revenue in Global (2018-2023)
7.2.5 VIVUS (Qsymia) Key News & Latest Developments
7.3 Novo Nordisk A/S
7.3.1 Novo Nordisk A/S Company Summary
7.3.2 Novo Nordisk A/S Business Overview
7.3.3 Novo Nordisk A/S Prescription Weight Loss Pills Major Product Offerings
7.3.4 Novo Nordisk A/S Prescription Weight Loss Pills Sales and Revenue in Global (2018-2023)
7.3.5 Novo Nordisk A/S Key News & Latest Developments
7.4 Rhythm Pharmaceuticals (Imcivree)
7.4.1 Rhythm Pharmaceuticals (Imcivree) Company Summary
7.4.2 Rhythm Pharmaceuticals (Imcivree) Business Overview
7.4.3 Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Major Product Offerings
7.4.4 Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Sales and Revenue in Global (2018-2023)
7.4.5 Rhythm Pharmaceuticals (Imcivree) Key News & Latest Developments
7.5 Eli Lilly and Company (TRICARE)
7.5.1 Eli Lilly and Company (TRICARE) Company Summary
7.5.2 Eli Lilly and Company (TRICARE) Business Overview
7.5.3 Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Major Product Offerings
7.5.4 Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Sales and Revenue in Global (2018-2023)
7.5.5 Eli Lilly and Company (TRICARE) Key News & Latest Developments
7.6 CHEPLAPHARM (Xenical)
7.6.1 CHEPLAPHARM (Xenical) Company Summary
7.6.2 CHEPLAPHARM (Xenical) Business Overview
7.6.3 CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Major Product Offerings
7.6.4 CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Sales and Revenue in Global (2018-2023)
7.6.5 CHEPLAPHARM (Xenical) Key News & Latest Developments
7.7 Pfizer
7.7.1 Pfizer Company Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Prescription Weight Loss Pills Major Product Offerings
7.7.4 Pfizer Prescription Weight Loss Pills Sales and Revenue in Global (2018-2023)
7.7.5 Pfizer Key News & Latest Developments
7.8 Teva Pharmaceutical (Actavis)
7.8.1 Teva Pharmaceutical (Actavis) Company Summary
7.8.2 Teva Pharmaceutical (Actavis) Business Overview
7.8.3 Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Major Product Offerings
7.8.4 Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Sales and Revenue in Global (2018-2023)
7.8.5 Teva Pharmaceutical (Actavis) Key News & Latest Developments
7.9 Haleon Group (alli)
7.9.1 Haleon Group (alli) Company Summary
7.9.2 Haleon Group (alli) Business Overview
7.9.3 Haleon Group (alli) Prescription Weight Loss Pills Major Product Offerings
7.9.4 Haleon Group (alli) Prescription Weight Loss Pills Sales and Revenue in Global (2018-2023)
7.9.5 Haleon Group (alli) Key News & Latest Developments
7.10 Sanofi (Adlyxin)
7.10.1 Sanofi (Adlyxin) Company Summary
7.10.2 Sanofi (Adlyxin) Business Overview
7.10.3 Sanofi (Adlyxin) Prescription Weight Loss Pills Major Product Offerings
7.10.4 Sanofi (Adlyxin) Prescription Weight Loss Pills Sales and Revenue in Global (2018-2023)
7.10.5 Sanofi (Adlyxin) Key News & Latest Developments
7.11 AstraZeneca (BYDUREON BCise)
7.11.1 AstraZeneca (BYDUREON BCise) Company Summary
7.11.2 AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Business Overview
7.11.3 AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Major Product Offerings
7.11.4 AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Sales and Revenue in Global (2018-2023)
7.11.5 AstraZeneca (BYDUREON BCise) Key News & Latest Developments
8 Global Prescription Weight Loss Pills Production Capacity, Analysis
8.1 Global Prescription Weight Loss Pills Production Capacity, 2018-2029
8.2 Prescription Weight Loss Pills Production Capacity of Key Manufacturers in Global Market
8.3 Global Prescription Weight Loss Pills Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Prescription Weight Loss Pills Supply Chain Analysis
10.1 Prescription Weight Loss Pills Industry Value Chain
10.2 Prescription Weight Loss Pills Upstream Market
10.3 Prescription Weight Loss Pills Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Prescription Weight Loss Pills Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LED Light-Up Blanket Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 116 |
Pelvic Floor Functional Magnetic Stimulator Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Multi-Modality Biofeedback System Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
High Frequency Evaluation and Therapy Device Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Choose License Type
Why Choose Us ?
24/7 Research support
Quality assurance
Information security
The report efficiently evaluates the market from various dimensions to deliver an
end-product that is informative, elaborate, and accurate and includes detailed
market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast.
The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of
xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the
industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market
opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE
analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing
initiatives, pricing analysis, competitive landscape which help businesses in
decision making. The analysis data is based on current and historical market trends
which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any
organization to gain insight into specific business sector, aligned with specific area
of interest. Thus, SMI offers more accurate, pragmatic, and actionable information
specifically tailored to suit your business needs.
